Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedJul 27, 20162 mcg/mL Fentanyl Citrate and 0.15% Bupivacaine HClPresence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.Pharmedium Services, LLC · D-1397-2016Class IITerminatedJul 27, 20162 mcg/mL Fentanyl Citrate and 0.125% Bupivacaine HClPresence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.Pharmedium Services, LLC · D-1396-2016Class IITerminatedJul 27, 20162 mcg/mL Fentanyl Citrate and 0.1% Bupivacaine HClPresence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.Pharmedium Services, LLC · D-1395-2016Class IITerminatedJul 27, 20162 mcg/mL Fentanyl Citrate and 0.083% Bupivacaine HClPresence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.Pharmedium Services, LLC · D-1394-2016Class IITerminatedJul 27, 20162 mcg/mL Fentanyl Citrate and 0.08% Bupivacaine HClPresence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.Pharmedium Services, LLC · D-1393-2016Class IITerminatedJul 27, 20162 mcg/mL Fentanyl Citrate and 0.075% Bupivacaine HClPresence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.Pharmedium Services, LLC · D-1392-2016Class IITerminatedJul 27, 20162 mcg/mL Fentanyl Citrate and 0.0625% Bupivacaine HClPresence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.Pharmedium Services, LLC · D-1391-2016Class IITerminatedJul 27, 20162 mcg/mL Fentanyl Citrate and 0.06% Bupivacaine HClPresence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.Pharmedium Services, LLC · D-1390-2016Class IITerminatedJul 27, 20162 mcg/mL Fentanyl Citrate and 0.25% Bupivacaine HClPresence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.Pharmedium Services, LLC · D-1389-2016Class IITerminatedJul 27, 201616.67 mcg/mL Fentanyl Citrate and 0.1667% Bupivacaine HClPresence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.Pharmedium Services, LLC · D-1388-2016Class IITerminatedJul 27, 201610 mcg/mL HYDROmorphone HCl and 0.125% Bupivacaine HClPresence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.Pharmedium Services, LLC · D-1387-2016Class IITerminatedJul 27, 201610 mcg/mL HYDROmorphone HCl and 0.1% Bupivacaine HClPresence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.Pharmedium Services, LLC · D-1386-2016Class IITerminatedJul 27, 201610 mcg/mL HYDROmorphone HCl and 0.075% Bupivacaine HClPresence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.Pharmedium Services, LLC · D-1385-2016Class IITerminatedJul 27, 201610 mcg/mL HYDROmorphone HCl and 0.0625% Bupivacaine HClPresence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.Pharmedium Services, LLC · D-1384-2016Class IITerminatedJul 27, 201610 mcg/mL HYDROmorphone HCl and 0.0625% Bupivacaine HCl in 0.9% Sodium ChloridePresence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.Pharmedium Services, LLC · D-1383-2016Class IITerminatedJul 27, 201610 mcg/mL Fentanyl Citrate and 0.2% Bupivacaine HClPresence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.Pharmedium Services, LLC · D-1382-2016Class IITerminatedJul 27, 201610 mcg/mL Fentanyl Citrate and 0.125% Bupivacaine HClPresence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.Pharmedium Services, LLC · D-1381-2016Class IITerminatedJul 27, 201610 mcg/mL Fentanyl Citrate and 0.1% Bupivacaine HClPresence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.Pharmedium Services, LLC · D-1380-2016Class IITerminatedJul 27, 201610 mcg/mL Fentanyl Citrate and 0.075% Bupivacaine HClPresence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.Pharmedium Services, LLC · D-1379-2016Class IITerminatedJul 27, 201610 mcg/mL Fentanyl Citrate and 0.0625% Bupivacaine HClPresence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.Pharmedium Services, LLC · D-1378-2016Class IITerminatedJul 27, 20161.5 mcg/mL Fentanyl Citrate and 0.125% Bupivacaine HClPresence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.Pharmedium Services, LLC · D-1377-2016Class IITerminatedJul 27, 20161 mcg/mL Sufentanil Citrate and 0.1% Bupivacaine HClPresence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.Pharmedium Services, LLC · D-1376-2016Class IITerminatedJul 27, 20161 mcg/mL Fentanyl Citrate and 0.125% Bupivacaine HClPresence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.Pharmedium Services, LLC · D-1375-2016Class IITerminatedJul 27, 20161 mcg/mL Fentanyl Citrate and 0.1% Bupivacaine HClPresence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.Pharmedium Services, LLC · D-1374-2016Class IITerminatedJul 27, 20161 mcg/mL Fentanyl Citrate and 0.08% Bupivacaine HClPresence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.Pharmedium Services, LLC · D-1373-2016Class IITerminatedJul 27, 20160.5% Bupivacaine HClPresence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.Pharmedium Services, LLC · D-1372-2016Class IITerminatedJul 27, 20160.5 mcg/mL Sufentanil Citrate and 0.1% Bupivacaine HClPresence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.Pharmedium Services, LLC · D-1371-2016Class IITerminatedJul 27, 20160.4 mcg/mL Sufentanil Citrate and 0.1% Bupivacaine HClPresence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.Pharmedium Services, LLC · D-1370-2016Class IITerminatedJul 27, 20160.4 mcg/mL Sufentanil Citrate and 0.0625% Bupivacaine HClPresence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.Pharmedium Services, LLC · D-1369-2016Class IITerminatedJul 27, 20160.25% Bupivacaine HClPresence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.Pharmedium Services, LLC · D-1368-2016Class IITerminatedJul 27, 20160.2% Bupivacaine HClPresence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.Pharmedium Services, LLC · D-1367-2016Class IITerminatedJul 27, 20160.15% Bupivacaine HClPresence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.Pharmedium Services, LLC · D-1366-2016Class IITerminatedJul 27, 20160.125% Bupivacaine HClPresence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.Pharmedium Services, LLC · D-1365-2016Class IITerminatedJul 27, 20160.1% Bupivacaine HClPresence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.Pharmedium Services, LLC · D-1364-2016Class IITerminatedJul 27, 20160.1 mg/mL Morphine Sulfate and 0.05% Bupivacaine HCIPresence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.Pharmedium Services, LLC · D-1363-2016Class IITerminatedJul 27, 20160.0625% Bupivacaine HClPresence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.Pharmedium Services, LLC · D-1362-2016Class IITerminatedJul 27, 20160.05 mg/mL Morphine Sulfate and 0.0625% Bupivacaine HCIPresence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.Pharmedium Services, LLC · D-1361-2016Class IITerminatedJul 27, 20160.03% Bupivacaine HClPresence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.Pharmedium Services, LLC · D-1360-2016Class IIITerminatedJul 20, 2016Oxycodone HClFailed Impurities/Degradation Specification; 9 month stabilityWest-Ward Columbus Inc · D-1441-2016Class IITerminatedJul 20, 2016DaytranaDefective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and z-statistic value which relates to the patients and caregiver...Noven Pharmaceuticals, Inc. · D-1440-2016